Analytical validation of a high-sensitivity cardiac troponin T assay

Clinical Chemistry

Volumn 56, Issue 2, 2010, Pages 254-261

  Giannitsis, Evangelos ^a   Kurz, Kerstin ^a   Hallermayer, Klaus ^b   Jarausch, Jochen ^b   Jaffe, Allan S ^c   Katus, Hugo A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN T; YOUNG ADULT;

EID: 75749150570     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.132654     Document Type: Article

References (27)

1. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28: 2525-38.
2. Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, et al. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem Lab Med 2009;47:227-34.
3. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, et al. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem 2007;53:220-7.
4. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007;116:1907-14.
5. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9.
6. Schulz O, Paul-Walter C, Lehmann M, Abraham K, Berghöfer G, Schimke I, Jaffe AS. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol 2007;100:764-9.
7. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and death in 70-year-old apparently healthy men. Circulation 2006;113:1071-8.
8. Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008;52:450-9.
9. Eggers KM, Lind L, Ahlström H, Bjerner T, Barbier CE, Larsson A, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I level in a population-based sample of elderly subjects. Eur Heart J 2008;29:2252-8.
10. Erler K. Elecsys® immunoassay system using electrochemiluminescence detection. Wien Klin Wochenschr 1998;110(Suppl 3):5-10.
11. Passing H, Bablok W. A general regression procedure for method transformation. J Clin Chem Clin Biochem 1988;26:783-90.
12. NCCLS. Protocols for determination of limits of detection and limits of quantitation; approved guideline 2004. NCCLS document EP17-A (ISBN 1-56238-551-8).
13. NCCLS. Evaluation of precision performance of quantitative measurement methods; approved guideline - second edition 2004. NCCLS document EP5-A2 (ISBN 1-56238-542-9).
14. Glick MR. Interferographs: user's guide to interferences in Clinical Chemistry Instruments. 2nd ed. Indianapolis: Science Enterprises; 1991.
15. Alpert JS, Thygesen K, Antman EM, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
16. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007;115:e356-75.
17. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J 2003;146:446-52.
18. Melanson SEF, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;128: 282-6.
19. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
20. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
21. Morrow DA. Clinical application of sensitive troponin assays. N Engl J Med 2009;361:913-5.
22. Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002;106:2871-2.
23. Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, Katus HA. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-7.
24. Lankeit M, Dellas C, Panzenboeck A, Skoro-Sajer N, Bonderman D, Olschewski M, et al. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:1024-9.
25. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
26. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006;27:330-7.
27. Peacock WF 4th, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH; ADHERE Investigators. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358: 2117-26.